Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
1.560
-0.020 (-1.27%)
At close: Apr 22, 2026, 4:00 PM EDT
1.550
-0.010 (-0.64%)
After-hours: Apr 22, 2026, 7:59 PM EDT
Boundless Bio Market Cap
Boundless Bio has a market cap or net worth of $34.96 million as of April 22, 2026. Its market cap has increased by 20.58% in one year.
Market Cap
34.96M
Enterprise Value
-23.81M
1-Year Change
20.58%
Ranking
Category
Stock Price
$1.56
Market Cap Chart
Since the IPO on March 28, 2024, Boundless Bio's market cap has decreased from $355.83M to $34.96M, a decrease of -90.18%. That is a compound annual growth rate of -67.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 35.40M | 31.80% |
| Dec 31, 2025 | 26.86M | -58.46% |
| Dec 31, 2024 | 64.67M | -81.83% |
| Mar 28, 2024 | 355.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NextCure | 38.92M |
| Veru Inc. | 38.20M |
| CervoMed | 37.78M |
| Palatin Technologies | 37.07M |
| INmune Bio | 37.03M |
| Evaxion | 36.95M |
| Tevogen Bio Holdings | 35.06M |
| Senti Biosciences | 34.88M |